GlassScriptPhysician profile
Leilani Pathak
NPI 1730640855
$1,342.03
in general payments reported to CMS, 2019-2025
18 companies · $1,310 in 2025
The $1,310 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $32.00 · 2025: $1,310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,229 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,229.14 |
| Education | $112.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $267.99 | 2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $149.46 | 2025 | Veozah |
| Amgen INC. | $114.84 | 2024-2025 | Evenity, Repatha, Otezla |
| Medtronic, INC. | $110.82 | 2025 | Symplicity G3, Minimed 780g |
| Insulet Corporation | $108.53 | 2025 | Omnipod |
| Viiv Healthcare Company | $98.56 | 2025 | Apretude |
| Lilly USA, LLC | $83.79 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Abbvie INC. | $80.27 | 2025 | |
| Dexcom, INC. | $58.72 | 2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $46.89 | 2025 | Shingrix, Arexvy |
| Exact Sciences Corporation | $45.20 | 2025 | Cologuard Collection Kit |
| Aerin Medical INC. | $41.67 | 2025 | |
| Sanofi-Aventis U.S. LLC | $29.82 | 2025 | |
| Alk-Abello, INC | $27.95 | 2025 | Neffy |
| Abbott Laboratories | $23.41 | 2025 | Freestyle Libre 3 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $22.42 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Merck Sharp & Dohme LLC | $17.08 | 2025 | Capvaxive, Gardasil 9 |
| Seqirus USA INC | $14.61 | 2025 | Flucelvax, Fluad |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leilani Pathak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.